Daxor Return on Tangible Equity 2010-2011 | DXR

Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Daxor Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2011-12-31 $-0.01B $0.04B -14.46%
2011-09-30 $0.00B $0.04B -6.78%
2011-06-30 $0.00B $0.05B 8.56%
2011-03-31 $0.00B $0.05B 8.70%
2010-12-31 $0.01B $0.05B 10.81%
2010-09-30 $0.00B $0.05B 4.30%
2010-06-30 $0.00B $0.04B 4.26%
2010-03-31 $0.01B $0.05B 16.84%
2009-12-31 $0.01B $0.05B 13.71%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.044B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.070B 19.78
Encompass Health (EHC) United States $12.070B 25.59
DaVita (DVA) United States $10.252B 14.41
Chemed (CHE) United States $7.989B 25.11
Elanco Animal Health (ELAN) United States $6.620B 14.18
Option Care Health (OPCH) United States $5.168B 23.04
RadNet (RDNT) United States $4.286B 272.00
Amedisys (AMED) United States $3.213B 21.61
Addus HomeCare (ADUS) United States $2.119B 23.26
LifeStance Health (LFST) United States $1.917B 0.00
Astrana Health (ASTH) United States $1.360B 33.69
U.S Physical Therapy (USPH) United States $1.121B 28.94
Pennant (PNTG) United States $0.967B 35.52
Aveanna Healthcare Holdings (AVAH) United States $0.935B 53.22
Atai Life Sciences (ATAI) Germany $0.467B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00